This dropshipping operation generated $34.4K monthly revenue with 36.7% margins and trades at 2.08x annual profit—valuations well within range for an established business. However, a buyer must independently verify several material claims: the sustainability of the 51% direct-traffic mix (partly dependent on seller-retained affiliate sites), customer acquisition cost and retention metrics, regulatory compliance in the telehealth/compounded-medication space, and whether the three included affiliate sites have durable organic ranking and referral quality. The 14-month operating history provides some track record, but the medical/telehealth niche carries execution and compliance risk that requires detailed operational due diligence.
The core software (e-commerce platform, telemedicine intake, prescription fulfillment integration) can be built with AI-assisted development using Shopify/custom React, Stripe, telehealth APIs, and managed databases in 6 weeks for $8–18K. However, the business being acquired is primarily the operational network: three affiliate sites with established organic search ranking and referral authority, verified customer relationships, a tested prescriber and pharmacy-partner network, and 14 months of revenue history demonstrating demand in a regulated niche. Rebuilding that customer acquisition and distribution engine from zero—including organic search authority, affiliate relationships, and telehealth partnerships—would take months to years and carry regulatory and market risk far exceeding the software cost. The buyer is purchasing traction, compliance infrastructure, and customer relationships, not primarily technology.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
Launched in July 2025, this US-based Dropshipping business operates in the perimenopause and menopause telehealth niche, offering provider-led compounded GLP-1 medications and Hormone Replacement Therapy (HRT) to patients across all 50 states and Washington, D.C. Key strengths include a streamlined fulfillment model with no inventory handling, nationwide coverage through a network of partner pharmacies, and an established flow of customers from organic, referral, and direct traffic sources. The business generates its revenue through sales of telehealth treatments, including compounded tirzepatide and semaglutide in injectable, oral dissolvable, and microdose formats, alongside HRT treatments. Traffic is approximately 51% Direct, 28% Organic Search, and 15% Referral, with a significant portion of direct traffic generated by affiliate websites operated by the seller. Three of these five affiliate sites are available to be included in the sale, while the seller will retain two that are personally branded around himself and his wife. Importantly, the affiliate revenue generated by the included sites has not been incorporated into the business P&L, giving a buyer the opportunity to benefit from additional revenue beyond the reported financial performance. The operation does not hold inventory. A third-party telehealth and fulfillment partner manages the patient portal, 24/7 customer care, provider review process, prescriptions, and coordination with partner pharmacies, which ship medications directly to patients. The seller currently spends approximately 10–30 hours per week primarily on SEO, content creation, website improvements, and optional customer support oversight. With no paid advertising currently in use, there is substantial room to expand customer acquisition through Google Ads, Meta Ads, affiliates, influencers, further SEO content development, and additional affiliate sites. The established infrastructure, nationwide fulfillment capability, additional unreported affiliate revenue, and minimal reliance on paid acquisition make this an attractive opportunity for a buyer looking to scale an existing telehealth platform. Owner works ~20 hours/week. Reason for sale: The Seller is no longer interested in the niche and would like to focus on projects he has personal experience with. Growth opportunities: Expanding paid traffic through Google and Meta; Recruiting affiliates and influencers while securing placements on best-of lists; Growing the blog with more SEO-focused content; Building affiliate sites reviewing GLP-1 and HRT telehealth companies for cross-sell traffic
Opens the original listing on Empire Flippers
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.